The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All.

Area of Science:

• Neuroscience and Neurology
• Public Health and Epidemiology

Background:

• Alzheimer's disease and dementia pathology begin years before cognitive symptoms manifest, complicating early prediction.
• Individuals with early cognitive complaints pose a diagnostic challenge for clinicians regarding dementia progression.
• Public interest is growing in accessing dementia risk evidence (DRE), including biomarkers and genetic data, for proactive health management.

Discussion:

• Researchers face dilemmas in sharing DRE due to validation concerns and potential misuse, including discrimination and stigma.
• Effective communication of DRE necessitates addressing risks, benefits, and knowledge gaps for all stakeholders.
• The Advisory Group on Risk Evidence Education for Dementia (AGREEDementia) promotes collaborative discussion on DRE sharing and utilization.

Key Insights:

• Dementia risk evidence can empower individuals to pursue early interventions and lifestyle changes.
• Understanding DRE is crucial for clinicians to guide diagnosis and patient management effectively.
• Responsible communication frameworks are essential to mitigate potential harms associated with knowing one's dementia risk.

Outlook:

• AGREEDementia serves as a model for interdisciplinary collaboration in managing health-related risk information.
• Future efforts should focus on developing validated DRE tools and ethical guidelines for their application.
• Enhanced education for clinicians, patients, and the public is vital for the appropriate use of dementia risk information.